Alzamend Neuro, Inc. Contracts & Agreements

At-The-Market Issuance Sales Agreement, dated September 8, 2023, with Ascendiant Capital Markets, LLC (Filed With SEC on September 8, 2023)

Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms with the University of South Florida Research Foundation, Inc., dated April 16, 2023 (Filed With SEC on July 27, 2023)

Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms Number LIC19050 with the University of South Florida Research Foundation, Inc., dated April 16,... (Filed With SEC on July 27, 2023)

Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms Number LIC19051 with the University of South Florida Research Foundation, Inc., dated April 16,... (Filed With SEC on July 27, 2023)

Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms Number LIC18110 with the University of South Florida Research Foundation, Inc., dated June 8, 2023 (Filed With SEC on July 27, 2023)

Form of Amendment to Standard Exclusive License Agreement with Sublicensing Terms Number LIC18111 with the University of South Florida Research Foundation, Inc., dated June 8, 2023 (Filed With SEC on July 27, 2023)

Executive Employment Agreement with Stephan Jackman dated June 17, 2021 (Filed With SEC on June 22, 2021)

Underwriting Agreement (Filed With SEC on May 25, 2021)

Board Letter Agreement, dated May 6, 2021, between Alzamend Neuro, Inc. and Milton C. Ault III (Filed With SEC on May 25, 2021)

Transition Services Consulting Agreement with William B. Horne dated December 1, 2018 (Filed With SEC on May 10, 2021)

Note Receivable Agreement with Avalanche International Corp. dated April 10, 2018 (Filed With SEC on May 10, 2021)

Securities Purchase Agreement with Ault Global Holdings, Inc. dated August 31, 2020 (Filed With SEC on May 10, 2021)

Category

Industry

Companies

Contracts

Alzamend Neuro, Inc. Contracts & Agreements